Multiple Myeloma Clinical Trial
Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer
Summary
Vertebral augmentation with radiotherapy to increase the functional status and quality of life for patients with vertebral body metastatic cancers.
Full Description
The study quantifies the reduction of pain and changes in quality of life associated with vertebral augmentation. This study is conducted in patients with metastatic cancer or multiple myeloma involving the spine. This study addresses the value of vertebral augmentation in combination with radiotherapy in the setting of cancer to the spine. The patient's pain, overall quality of life, and fracture development/avoidance will be compared to patients treated only with radiotherapy in the past.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of metastatic disease to the vertebra or multiple myeloma
Negative pregnancy test within 2 weeks prior to registration
Life expectancy of >= 3 months and Karnofsky performance status (KPS) score >= 40
Pain scale score >=5
Pain at involved vertebral body not adequately controlled
Osteolysis of vertebral bodies
Must agree to practice adequate means of birth control
Must sign informed consent prior to study entry
Must be able to understand the English language
Absence of any serious cognitive or psychiatric problems potentially hampering compliance with the study and follow-up schedule.
Exclusion Criteria:
Spinal Cord Compression
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Tucson Arizona, 85724, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.